Abiraterone
The serum concentration of Amsacrine can be increased when it is combined with Abiraterone.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Amsacrine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Amsacrine.
Advertisement
Amiodarone
The metabolism of Amsacrine can be decreased when combined with Amiodarone.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Amsacrine.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Amsacrine.
Advertisement
Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Amsacrine.
Artemether
The metabolism of Amsacrine can be decreased when combined with Artemether.
Atomoxetine
The metabolism of Amsacrine can be decreased when combined with Atomoxetine.
Advertisement
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Amsacrine.
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Amsacrine.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Amsacrine.
Betaxolol
The metabolism of Amsacrine can be decreased when combined with Betaxolol.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Amsacrine.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Amsacrine.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Amsacrine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Amsacrine.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Amsacrine.
Bupropion
The metabolism of Amsacrine can be decreased when combined with Bupropion.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Amsacrine.
Celecoxib
The metabolism of Amsacrine can be decreased when combined with Celecoxib.
Chloroquine
The metabolism of Amsacrine can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Amsacrine can be decreased when combined with Chlorpromazine.
Cholecalciferol
The metabolism of Amsacrine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Amsacrine can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Amsacrine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Amsacrine can be decreased when combined with Citalopram.
Clemastine
The metabolism of Amsacrine can be decreased when combined with Clemastine.
Clobazam
The metabolism of Amsacrine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Amsacrine can be decreased when combined with Clomipramine.
Clotrimazole
The metabolism of Amsacrine can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Amsacrine is combined with Clozapine.
Cobicistat
The serum concentration of Amsacrine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Amsacrine can be decreased when combined with Cocaine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Amsacrine.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Amsacrine.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Amsacrine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Amsacrine.
Darifenacin
The metabolism of Amsacrine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Amsacrine can be increased when it is combined with Darunavir.
Delavirdine
The metabolism of Amsacrine can be decreased when combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Amsacrine.
Desipramine
The metabolism of Amsacrine can be decreased when combined with Desipramine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Amsacrine.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Amsacrine.
Digoxin
Digoxin may decrease the cardiotoxic activities of Amsacrine.
Diphenhydramine
The metabolism of Amsacrine can be decreased when combined with Diphenhydramine.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Amsacrine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Amsacrine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Amsacrine.
Dothiepin
The metabolism of Amsacrine can be decreased when combined with Dosulepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Amsacrine.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Amsacrine.
Dronedarone
The metabolism of Amsacrine can be decreased when combined with Dronedarone.
Duloxetine
The metabolism of Amsacrine can be decreased when combined with Duloxetine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Amsacrine.
Eliglustat
The metabolism of Amsacrine can be decreased when combined with Eliglustat.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Amsacrine.
Fingolimod
Amsacrine may increase the immunosuppressive activities of Fingolimod.
Fluoxetine
The metabolism of Amsacrine can be decreased when combined with Fluoxetine.
Fluvoxamine
The metabolism of Amsacrine can be decreased when combined with Fluvoxamine.
Haloperidol
The metabolism of Amsacrine can be decreased when combined with Haloperidol.
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Amsacrine.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Amsacrine.
Imipramine
The metabolism of Amsacrine can be decreased when combined with Imipramine.
Indinavir
The metabolism of Amsacrine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Amsacrine can be decreased when combined with Indinavir.
Isoniazid
The metabolism of Amsacrine can be decreased when combined with Isoniazid.
Ketoconazole
The metabolism of Amsacrine can be decreased when combined with Ketoconazole.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Amsacrine.
Leflunomide
The risk or severity of adverse effects can be increased when Amsacrine is combined with Leflunomide.
Lopinavir
The metabolism of Amsacrine can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Amsacrine can be decreased when combined with Lorcaserin.
Lumefantrine
The metabolism of Amsacrine can be decreased when combined with Lumefantrine.
Manidipine
The metabolism of Amsacrine can be decreased when combined with Manidipine.
Methadone
The metabolism of Amsacrine can be decreased when combined with Methadone.
Methotrimeprazine
The metabolism of Amsacrine can be decreased when combined with Methotrimeprazine.
Metoprolol
The metabolism of Amsacrine can be decreased when combined with Metoprolol.
Midostaurin
The metabolism of Amsacrine can be decreased when combined with Midostaurin.
Mirabegron
The metabolism of Amsacrine can be decreased when combined with Mirabegron.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Amsacrine.
Natalizumab
The risk or severity of adverse effects can be increased when Amsacrine is combined with Natalizumab.
Nevirapine
The metabolism of Amsacrine can be decreased when combined with Nevirapine.
Nicardipine
The metabolism of Amsacrine can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Amsacrine can be decreased when combined with Nilotinib.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Amsacrine.
Ouabain
Ouabain may decrease the cardiotoxic activities of Amsacrine.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Amsacrine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Amsacrine.
Panobinostat
The serum concentration of Amsacrine can be increased when it is combined with Panobinostat.
Paroxetine
The metabolism of Amsacrine can be decreased when combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Amsacrine.
Peginterferon Alfa-2b
The serum concentration of Amsacrine can be decreased when it is combined with Peginterferon alfa-2b.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Amsacrine.
Promazine
The metabolism of Amsacrine can be decreased when combined with Promazine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Amsacrine.
Quinidine
The metabolism of Amsacrine can be decreased when combined with Quinidine.
Quinine
The metabolism of Amsacrine can be decreased when combined with Quinine.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Amsacrine.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Amsacrine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Amsacrine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Amsacrine.
Ritonavir
The metabolism of Amsacrine can be decreased when combined with Ritonavir.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Amsacrine.
Rolapitant
The metabolism of Amsacrine can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Amsacrine can be decreased when combined with Ropinirole.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Amsacrine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Amsacrine.
Rucaparib
The metabolism of Amsacrine can be decreased when combined with Rucaparib.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Amsacrine.
Sertraline
The metabolism of Amsacrine can be decreased when combined with Sertraline.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Amsacrine.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Amsacrine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Amsacrine.
Terbinafine
The metabolism of Amsacrine can be decreased when combined with Terbinafine.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Amsacrine.
Thioridazine
The metabolism of Amsacrine can be decreased when combined with Thioridazine.
Ticlopidine
The metabolism of Amsacrine can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Amsacrine can be decreased when combined with Tipranavir.
Tofacitinib
Amsacrine may increase the immunosuppressive activities of Tofacitinib.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Amsacrine.
Tranylcypromine
The metabolism of Amsacrine can be decreased when combined with Tranylcypromine.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Amsacrine.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Amsacrine.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Amsacrine.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Amsacrine.
Venlafaxine
The metabolism of Amsacrine can be decreased when combined with Venlafaxine.
Vincristine
The excretion of Vincristine can be decreased when combined with Amsacrine.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Amsacrine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Amsacrine.
Ziprasidone
The metabolism of Amsacrine can be decreased when combined with Ziprasidone.
